EUVIMED · CrossrefJournal
Journal of Hepatocellular Carcinoma
ISSN 2253-5969 · Informa UK Limited
Latest articles
Alcohol Dehydrogenase 1B (ADH1B) Inhibits Proliferation and Metastasis of Hepatocellular Carcinoma via Downregulating FoxM1 Pathway
Circular RNAs in Hepatocellular Carcinoma: Biogenesis, Detection, Functional Mechanisms, and Translational Evidence
Histotripsy for Hepatocellular Carcinoma in Asia-Pacific: Current Evidence, Evidence Gaps, and Future Research Priorities
Aquaporin 3 Promotes Invasion and Migration of Hepatocellular Carcinoma Cells via Glycerol-Dependent Remodeling of Phospholipid Homeostasis and Energy Metabolism
MRI-Based Assessment of Intratumoral Steatosis and Immunosuppressive Features in a Mouse Model of MAFLD-Associated Hepatocellular Carcinoma
HDDC2 Promotes HCC Progression Associated with AKT/mTOR/S6K1 Signaling
Targeting Ferroptosis-Mediated Tumor Microenvironment Remodeling in Hepatocellular Carcinoma: Therapeutic Resistance and Clinical Translation
Investigating the Expression and Function of PPP2R1A in Hepatocellular Carcinoma: A Multi-Omics Analysis with in vitro Validation
Hepatocellular Carcinoma Progression is Regulated by KIF4A via the HSP90-CDC37 Complex/AKT Pathway
Glutaminase Isoenzyme and Splice-Variant Remodeling in Hepatocellular Carcinoma: Redox Vulnerability, Ferroptosis, and Therapeutic Resistance
The Lactate–Lactylation Axis in Hepatocellular Carcinoma: Biological Functions, Tumor Microenvironment, and Therapeutic Implications
A Laboratory-Based Triage Model for Hepatocellular Carcinoma Early-Detection Pathways in Hospital-Evaluated Populations: Development and External Validation
Overall Survival Prediction and Treatment Risk Stratification in Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: Development and Validation of an Interpretable Machine Learning Model
Self-Attention-Based Deep-Learning Model Using Multimodal MRI to Predict Ki-67 Expression and Recurrence-Free Survival in Hepatocellular Carcinoma
Efficacy, Safety, and Exploratory Prognostic Factors of TACE-HAIC Plus Lenvatinib with Tislelizumab or Nivolumab in Unresectable Hepatocellular Carcinoma: A Retrospective Cohort Study
Immune Dynamics of Pathological Complete Response to Neoadjuvant Immunotherapy in Hepatocellular Carcinoma: Mechanisms, Biomarkers, and Prognostic Implications
Machine Learning Models Using Routine Clinical Data versus Conventional Clinical Scores for Survival Prediction in Hepatocellular Carcinoma: A Single-Center Study
Development and Internal Validation of an On-Treatment Nomogram for Hepatocellular Carcinoma Prediction in Chinese Patients with Chronic Hepatitis B Receiving Long-Term Nucleos(t)ide Analogue Therapy
Perihilar Co-Ablation for Pancreatic Cancer Liver Metastasis Adjacent to the Hepatic Pedicle: A Case Report and Literature Review
Safety and Efficacy of TACE Combined with Lenvatinib and Pembrolizumab in Advanced Hepatocellular Carcinoma (BCLC C): A Retrospective Study [Retraction]
AHSA1 Regulates Hepatocellular Carcinoma Progression via the TGF-β/Akt-Cyclin D1/CDK6 Pathway [Retraction]
Comprehensive Genomic Profiling Identifies FAT1 as a Negative Regulator of EMT, CTCs, and Metastasis of Hepatocellular Carcinoma [Retraction]
Etiology Dependent Differences in Immunotherapy Response and Prognosis Between MASH-HCC and HBV-HCC
Mechanisms of Resistance and Immune-Related Adverse Events Associated with Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: A Narrative Review
The Efficacy and Safety of Combined Locoregional and Systemic Therapy versus Systemic Therapy Alone in Patients with Hepatocellular Carcinoma and Portal Vein Tumor Thrombosis: A Multicenter Real-World Retrospective Cohort Study
Knowledge Mapping and Frontier Evolution of Traditional Medicine in Hepatocellular Carcinoma Research: A Bibliometric Analysis
Dysregulation of miRNA-2116-3p Predicts Prognosis of Hepatocellular Carcinoma and Regulates Tumor Cell Proliferation and Migration
Construction of a Nomogram Integrating Magnetic Resonance Imaging Features and Ephrin-A3 Expression to Predict Postoperative Overall Survival in Hepatocellular Carcinoma
Survival Outcomes in Patients with Advanced Hepatocellular Carcinoma Based on Pretreatment Serum Lactate Dehydrogenase Level and Albumin-Bilirubin Grade: A Single-Center, Retrospective, Non-Randomized Cohort Study
Isolated Metachronous Splenic Metastasis Following Discontinuation of PD-1 Inhibitor Therapy in Hepatocellular Carcinoma: A Rare Pattern of Late Recurrence — A Case Report
EUVIMED